Small-molecule and mutational analysis of allosteric Eg5 inhibition by monastrol
2006
Study of Monastrol's Effect on Eg5 Kinesin
publication
Evidence: moderate
Author Information
Author(s): Zoltan Maliga, Timothy J Mitchison
Hypothesis
What specific interactions stabilize the binding of monastrol to the Eg5 motor domain?
Conclusion
Monastrol's mechanism reveals its specificity for Eg5 and suggests a potential for drug resistance in anti-cancer therapies targeting Eg5.
Supporting Evidence
- Monastrol binds to a specific site on Eg5, which is crucial for its function during cell division.
- Mutations in the Eg5 binding site can lead to resistance against monastrol.
- The study confirmed the crystal structure of the Eg5-monastrol complex, supporting the findings.
Takeaway
Monastrol is a drug that helps researchers understand how a protein called Eg5 works during cell division, and it can help stop cancer cells from growing.
Methodology
The study used synthetic chemistry and targeted mutations to analyze the interaction between monastrol and the Eg5 motor domain.
Limitations
The specificity of monastrol may not be absolute, as it could potentially bind to other proteins at high concentrations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website